Dermata Therapeutics, Inc. (DRMAW) SEC Filings — 2024
17 SEC filings for Dermata Therapeutics, Inc. (DRMAW) in 2024.
Filings
- Dermata Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- Dermata Therapeutics Files 8-K on Financials — 8-K · Nov 14, 2024
- Dermata Therapeutics Files Q3 2024 10-Q — 10-Q · Nov 13, 2024
- Dermata Therapeutics Files 8-K on Equity Sales — 8-K · Sep 17, 2024
- Dermata Therapeutics Files Q2 2024 10-Q — 10-Q · Aug 7, 2024
- Dermata Therapeutics Files 8-K — 8-K · Aug 2, 2024
- Dermata Therapeutics Enters Material Definitive Agreement — 8-K · Jun 7, 2024
- Dermata Therapeutics Secures $1.5M Private Placement — 8-K · Jun 5, 2024
- Dermata Therapeutics Faces Delisting Concerns — 8-K · May 24, 2024
- Dermata Therapeutics Raises $1.5M via Stock and Warrant Sale — 8-K · May 17, 2024
- Dermata Therapeutics, Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 15, 2024
- Dermata Therapeutics Files 8-K for Corporate Updates — 8-K · May 14, 2024
- Dermata Therapeutics Appoints New Officers, Files 8-K — 8-K · May 7, 2024
- Dermata Therapeutics Schedules 2024 Annual Meeting of Stockholders for May 7 — DEF 14A · Mar 26, 2024
- Dermata Therapeutics Files 2023 Annual Report on Form 10-K — 10-K · Mar 21, 2024
- Dermata Therapeutics, Inc. SC 13G Filing — SC 13G · Feb 14, 2024
- DRMA Files 8-K on Shareholder Vote Submission — 8-K · Jan 12, 2024